Original Research

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients

Maoujoud O, Ahid S, Cherrah Y

International Journal of Nephrology and Renovascular Disease 2016, 9:35-43

Published Date: 24 February 2016